Dfmo and sulindac combination in cancer chemoprevention

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/195 (2006.01)

Patent

CA 2325080

Activation of the Ki-ras proto-oncogene is common in colon carcinogenesis. Non- steroidal anti-inflammatory drugs (NSAIDs) inhibit carcinogen-induced colon carcinogenesis, decrease the frequency of Ki-ras mutations in the azoxymethane- treated rat model, and induce apoptosis in a variety of cell types. Sulindac, as well as other non-steroidal anti-inflammatory agents, are provided in combination with DFMO for the prevention and/or treatment of cancers characterized by the expression of an activated Ki-ras. Provided with the present invention are pharmaceutically acceptable compositions that include a non-steroidal anti-inflammatory agent, sulindac, together with an effective amount of difluoromethylornithine.

L'activation du proto-oncogène Ki-ras est fréquente dans la carcinogenèse du colon. Des médicaments anti-inflammatoires non stéroïdaux (NSAID) empêchent la carcinogenèse du colon induite par le carcinogène, réduisent la fréquence de mutations Ki-ras dans le modèle de rat traité à l'azoxyméthane et induisent l'apoptose dans toute une gamme de types cellulaires. Le sulindac, ainsi que d'autres agents anti-inflammatoires non stéroïdaux sont administrés en combinaison avec de la .alpha.-difluorométhylornithine (DFMO) pour la prévention et/ou le traitement de cancers caractérisés par l'expression d'un Ki-ras activé. La présente invention concerne également des compositions pharmaceutiquement acceptables qui comportent un agent anti-inflammatoire non stéroïdal, le sulindac, en combinaison avec une quantité efficace de difluorométhylornithine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dfmo and sulindac combination in cancer chemoprevention does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dfmo and sulindac combination in cancer chemoprevention, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dfmo and sulindac combination in cancer chemoprevention will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1592299

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.